Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma: Protocol for the STOP-HCC phase 3 randomized controlled trial

TheraSphere STOP-HCC Protocol Study Group

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma: Protocol for the STOP-HCC phase 3 randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences